Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Periodontal Health and Treatment Outcomes in Students From Three Countries

16 de noviembre de 2026 actualizado por: Esra İlkerli Şençağlı

Investigation of the Prevalence, Severity, and Treatment Response of Periodontal Diseases Among Student Groups From Different Countries

This study aims to investigate the prevalence and severity of periodontal diseases among university students from three different national backgrounds (Iranian, Sudanese, and Turkish) and to evaluate their response to periodontal treatment.

A total of 348 students will be included in the study, comprising 116 Iranian, 116 Sudanese, and 116 Turkish students. Periodontal health assessments will be performed, and all participants will receive periodontal treatment according to the study protocol.

The study will compare periodontal disease prevalence and severity among the three groups and evaluate changes in periodontal health following treatment.

Descripción general del estudio

Estado

Reclutamiento

Intervención / Tratamiento

Descripción detallada

This study investigates the prevalence and severity of periodontal diseases among university students from three different national backgrounds and evaluates their response to periodontal treatment.

A total of 348 university students will be included in the study, consisting of 116 students of Iranian origin, 116 students of Sudanese origin, and 116 students of Turkish origin.

At baseline, all participants will undergo a comprehensive periodontal examination to assess their periodontal health status. Clinical periodontal parameters will be recorded using standardized periodontal assessment methods.

All participants will receive periodontal treatment according to the study protocol. The treatment includes professional scaling and oral hygiene instruction. Root planing will be performed when clinically indicated, depending on the periodontal condition of each participant.

Three weeks after treatment, participants will undergo a follow-up periodontal examination. Clinical periodontal parameters will be reassessed to evaluate changes in periodontal health and treatment response.

The findings will be compared among the three student groups to investigate differences in periodontal disease prevalence, severity, and response to treatment.

The study aims to provide information about periodontal health differences among students from different national backgrounds and their response to periodontal treatment.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

348

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Esra İlkerli Şençağlı, Dt.
  • Número de teléfono: +905338408701
  • Correo electrónico: esra.ilkerli@kstu.edu.tr

Ubicaciones de estudio

      • Mórfou, Chipre
        • Reclutamiento
        • Cyprus Health and Social Sciences University
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Being 18 years of age or older.
  • Having been born and raised in a country different from the country of current study.
  • Currently being enrolled as a student at Cyprus Health and Social Sciences University.
  • Having received no periodontal treatment within the previous six months.
  • Having at least 20 natural teeth.
  • Voluntarily agreeing to participate in the study and providing written informed consent.

Exclusion Criteria:

  • Completely edentulous individuals.
  • Individuals who have used systemic antibiotics or anti-inflammatory medications within the previous six months.
  • Individuals with a history of periodontal surgery.
  • Pregnant or breastfeeding individuals.
  • Individuals with immunosuppression due to systemic diseases or medical conditions (e.g., chemotherapy or HIV).

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Periodontal Treatment Group

All 348 participants will receive periodontal treatment according to their individual clinical needs. Treatment will include scaling and root planing when clinically indicated. Participants will be evaluated at baseline and reassessed three weeks after treatment to assess periodontal treatment outcomes.

Participants will receive non-surgical periodontal treatment according to their individual clinical needs. The treatment will include scaling and root planing where clinically indicated. The procedure will be performed based on baseline periodontal examination findings. All participants will be reassessed three weeks after treatment to evaluate changes in periodontal clinical parameters, including plaque index, gingival index, probing pocket depth, clinical attachment level, and tooth mobility.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Probing Pocket Depth (PPD)
Periodo de tiempo: Baseline and 3 weeks after periodontal treatment

Change in mean probing pocket depth (PPD) from baseline to the three-week follow-up after periodontal treatment. Measurements will be compared among Iranian, Sudanese, and Turkish student groups.

Baseline and 3 weeks after periodontal treatment

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Plaque Index (PI) Assessed Using the Silness and Löe Plaque Index
Periodo de tiempo: Baseline and 3 weeks

Dental plaque will be assessed clinically using the Silness and Löe Plaque Index (1964). Plaque accumulation will be scored on a scale ranging from 0 to 3:

0: No plaque.

  1. A film of plaque adhering to the free gingival margin and adjacent tooth area, detectable only by running a probe across the tooth surface.
  2. Moderate accumulation of soft deposits within the gingival pocket or on the tooth and gingival margin, visible to the naked eye.
  3. Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

The minimum score is 0 and the maximum score is 3. Higher scores indicate greater plaque accumulation and a worse oral hygiene outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment.

Baseline and 3 weeks
Change in Gingival Index (GI) Assessed Using the Löe and Silness Gingival Index
Periodo de tiempo: Baseline and 3 weeks

Gingival inflammation will be assessed clinically using the Löe and Silness Gingival Index (1963). Gingival tissues will be scored on a scale ranging from 0 to 3:

0: Normal gingiva, no inflammation.

  1. Mild inflammation, slight color change and slight edema, with no bleeding on probing.
  2. Moderate inflammation, redness, edema, and glazing, with bleeding on probing.
  3. Severe inflammation, marked redness and edema, ulceration, and a tendency to spontaneous bleeding.

The minimum score is 0 and the maximum score is 3. Higher scores indicate more severe gingival inflammation and a worse periodontal outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment.

Baseline and 3 weeks
Change in Clinical Attachment Level (CAL)
Periodo de tiempo: Baseline and 3 weeks
Baseline and 3 weeks
Change in Tooth Mobility Assessed Using the Miller Mobility Index
Periodo de tiempo: Baseline and 3 weeks

Tooth mobility will be assessed clinically using the Miller Mobility Index. Each examined tooth will be evaluated for horizontal and vertical mobility using two rigid instrument handles. Mobility will be classified as follows:

Grade 0: Physiologic tooth mobility. Grade 1: Slight horizontal mobility of less than 1 mm. Grade 2: Horizontal mobility of more than 1 mm without vertical mobility. Grade 3: Severe horizontal mobility accompanied by vertical mobility.

Higher grades indicate greater tooth mobility and a worse periodontal outcome. Tooth mobility will be assessed at baseline and 3 weeks after periodontal treatment.

Baseline and 3 weeks
Change in Bleeding on Probing (BOP) Percentage
Periodo de tiempo: Baseline and 3 weeks

Bleeding on probing (BOP) will be assessed as a clinical indicator of gingival inflammation using a periodontal probe. The periodontal probe will be gently inserted into the gingival sulcus to evaluate the presence or absence of bleeding following probing.

Each periodontal site will be recorded using a dichotomous scoring system:

Score 0: Absence of bleeding on probing. Score 1: Presence of bleeding on probing.

The BOP percentage will be calculated by dividing the total number of bleeding-positive sites by the total number of examined periodontal sites and multiplying by 100.

BOP (%) = (Number of bleeding-positive sites / Total number of examined sites) × 100.

The minimum value is 0% and the maximum value is 100%. Higher percentages indicate a greater proportion of bleeding sites and more pronounced gingival inflammation.

Baseline and 3 weeks
Prevalence and Severity of Periodontal Disease
Periodo de tiempo: Baseline
Baseline

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Silla de estudio: Halil İbrahim Taşer, Prof.Dr., Cyprus Health and Social Sciences University
  • Investigador principal: Esra İlkerli Şençağlı, Dt., Cyprus Health and Social Sciences University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

6 de mayo de 2026

Finalización primaria (Estimado)

6 de mayo de 2029

Finalización del estudio (Estimado)

6 de mayo de 2029

Fechas de registro del estudio

Enviado por primera vez

6 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

16 de noviembre de 2026

Publicado por primera vez (Actual)

18 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

16 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir